Littérature scientifique sur le sujet « Major psychoses »
Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres
Consultez les listes thématiques d’articles de revues, de livres, de thèses, de rapports de conférences et d’autres sources académiques sur le sujet « Major psychoses ».
À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.
Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.
Articles de revues sur le sujet "Major psychoses"
McGuire, P. K., P. Jones, P. McGuffin et R. M. Murray. « ‘Cannabis psychosis’ and the major psychoses ». Schizophrenia Research 9, no 2-3 (avril 1993) : 104. http://dx.doi.org/10.1016/0920-9964(93)90126-4.
Texte intégralGuinness, E. A. « II. Brief Reactive Psychosis and the Major Functional Psychoses : Descriptive Case Studies in Africa ». British Journal of Psychiatry 160, S16 (avril 1992) : 24–41. http://dx.doi.org/10.1192/s0007125000296773.
Texte intégralUngvari, Gabor Sandor, et Paul Edward Mullen. « Reactive Psychoses Revisited ». Australian & ; New Zealand Journal of Psychiatry 34, no 3 (juin 2000) : 458–67. http://dx.doi.org/10.1080/j.1440-1614.2000.00752.x.
Texte intégralSCHRIFT, MICHAEL J., HANUMAIAH BANDLA, PRAMOD SHAH et MICHAEL ALAN TAYLOR. « Interhemispheric Transfer in Major Psychoses ». Journal of Nervous and Mental Disease 174, no 4 (avril 1986) : 203–7. http://dx.doi.org/10.1097/00005053-198604000-00002.
Texte intégralFilatova, S., R. Marttila, H. Koivumaa-Honkanen, T. Nordström, J. Veijola, P. Mäki, G. M. Khandaker et al. « A comparison of the cumulative incidence and early risk factors for psychotic disorder in young adults in the Northern Finland Birth Cohorts 1966 and 1986 ». Epidemiology and Psychiatric Sciences 26, no 3 (28 mars 2016) : 314–24. http://dx.doi.org/10.1017/s2045796016000123.
Texte intégralHorn, Rolf. « The Concept of Delirium in German-Speaking Psychiatry ». International Psychogeriatrics 3, no 2 (décembre 1991) : 209–10. http://dx.doi.org/10.1017/s1041610291000674.
Texte intégralEcheverría Hernández, N., M. D. M. Lázaro Redondo, F. de la Torre Brasas, A. Duque Domínguez, A. Mas Villaseñor, C. García Montero, L. Martín Díaz et M. Otalora Navarro. « Psychoses of epilepsy – “Acute attacks of insanity”. What literature says and how we act ». European Psychiatry 33, S1 (mars 2016) : S630. http://dx.doi.org/10.1016/j.eurpsy.2016.01.2364.
Texte intégralLloyd, Andrew, Gavin Dixon, Xu Feng Huang, Phillip Ward, Stan Catts, Ian Hickie et Denis Wakefield. « Molecular Biology and the Major Psychoses ». Australian & ; New Zealand Journal of Psychiatry 31, no 1 (février 1997) : 12–16. http://dx.doi.org/10.3109/00048679709073794.
Texte intégralKanba, S., G. Yagi, T. Suzuki et K. Kamijima. « ZONISAMIDE IN EXCITEMENT OF MAJOR PSYCHOSES ». Clinical Neuropharmacology 15 (1992) : 441B. http://dx.doi.org/10.1097/00002826-199202001-00857.
Texte intégralSerretti, Alessandro, Roberta Lilli, Cristina Lorenzi, Enrico Lattuada, Cristina Cusin et Enrico Smeraldi. « Tryptophan hydroxylase gene and major psychoses ». Psychiatry Research 103, no 1 (août 2001) : 79–86. http://dx.doi.org/10.1016/s0165-1781(01)00269-4.
Texte intégralThèses sur le sujet "Major psychoses"
Birkett, Joseph Thomas Patrick. « The molecular genetics of the major psychoses ». Thesis, King's College London (University of London), 2001. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.367730.
Texte intégralDixon, Tracy Anne. « The neuropsychology and functional anatomy of verbal fluency in the major psychoses ». Thesis, King's College London (University of London), 2000. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.322578.
Texte intégralLotter, C. B. « The qualitative affordances of active and receptive music therapy techniques in major depressive disorder and schizophrenia-spectrum psychotic disorders ». Thesis, University of Pretoria, 2017. http://hdl.handle.net/2263/63046.
Texte intégralThesis (PhD)--University of Pretoria, 2017.
Psychiatry
PhD
Unrestricted
Sá, Helena Pinho de. « Transtorno Depressivo Maior (TDM) com e sem sintomas psicóticos : investigação neuroquímica por espectroscopia de próton ». Universidade de São Paulo, 2011. http://www.teses.usp.br/teses/disponiveis/17/17148/tde-15122011-183318/.
Texte intégralIntroduction: Major depressive disorder (MDD) is one of the most prevalent and disabling of mental disorders. Nevertheless, its classification is still based on signs and symptoms, since its causes and pathophysyology has not been fully clarified. The presence of psychotic symptoms are relatively common during a depressive episode and is associated with clinical and biological peculiarities, but is underdiagnosed and its pathophysiology have been insufficiently studied, especially when considering the extensive literature on non-psychotic forms of depression. The aim of this study is to investigate the neurochemistry of the anterior cingulated gyrus (AC), a brain\'s neurocircuitry constituent related to the pathophysiology of MDD with psychosis/in the form of psychotic disorder. For this propose, we compared/ were compared the results of the metabolites between groups of patients with MDD with and without psychotic symptoms and controls by- proton resonance spectroscopy imaging of hydrogen (1rH-MRS). Secondly, the interference of socio-demographic and clinical on the cerebral metabolites. It was expected that patients with psychotic symptoms (MDD-P) present neurochemical changes in relation to the group of health controls and patients with depression without psychotic symptoms (MDD-Wo), regardless of the severity of depression symptons. Methods: The groups were diagnosed by the Structured Clinical Interview for DSM-IV (SCID). The severity of depressive and psychotic symptoms, as well as the level of overall functioning were assessed using the Hamilton Rating Scale, BPRS and GAF (respectively). We collected information about the history of suicide attempts, drug treatment, psychiatric and medical comorbidities.1\'H-MRS single voxel, with echo time (TE) short (3lms) in a magnetic field of 3.0 Tesla was used for the evaluation of CA in 20 patients with MDD-P, 22 with MDD-Wo and 20 healthy subjects. We analyzed the absolutevalues of glutamate (Glu), glutamate plus glutamine (Gln+Glu), N-acetylaspartate plus N-acetyl aspartate-glutamate (NAA+NAAG), glycerol phosphorylcholine plus phosphorylcholine plus choline (PC+GPC), myo-inositol (Myo) and creatine (Cr). Data on socio-demographic and clinical information were analyzed using ANOVA and chi-square, while the levels of metabolites were compared by MANOVA. The statistical significance level used was p <0.05. Results: Patients with MDD-P had less schooling and poorer overall functioning, both in relation to the controls as compared to patients without psychosis. Patient groups did not differ in the severity of depressive symptoms. Glu levels of MDD-P were lower than the MDD-Wo and the control group; NAA+NAAG levels of MDD-P were lower than in control and GPC+PC levels of MDDP were lower than the MDD-Wo. Between the sexes, Glu and NAA + NAAG levels of males were lower than females. Finally, Glu, Glu+Gln and Cr levels were different between the sexes within the groups. Conclusion:The group levels of metabolites of CA have been interfered with diagnosis and the effect of gender and gender-diagnosis interaction were close to be meaningful. The differences in the levels of Glu, NAA + NAAG and GPC + PC between diagnoses are possibly related to higher hypercortisolemia found in the MDD-P and the brain concentration of kynurenine metabolites imballance more similar with schizophrenia than MDD. The interference of sex for the levels of Glu and NAA + NAAG suggests a protective role of female hormones to glutamatergic system and cycle of the NAA. Still, probably the severity of the depressive episodes not implicated in the neurochemical differences between MDD-P and MDD-Wo
Melton, Ryan P. « Family aided community treatment as an intervention for the treatment of early psychosis : a proof of concept study ». Thesis, 2012. http://hdl.handle.net/1957/29049.
Texte intégralGraduation date: 2012
Yazdanpanah, Simin. « Search for DNA methylation differences in major psychosis ». 2007. http://link.library.utoronto.ca/eir/EIRdetail.cfm?Resources__ID=788841&T=F.
Texte intégralMeei, Lee Feng, et 李鳳美. « The Effects of Psychosocial Stress and Social Support on Burden among Caregivers of Major Psychosis Adolescents ». Thesis, 2007. http://ndltd.ncl.edu.tw/handle/42406357745726302620.
Texte intégral國立台北護理學院
護理研究所
95
ABSTRACT This study was grounded on theories of stress and social support to explore the relationship between psychosocial stress, social support and the burden among caregivers of psychosis adolescents. The main purpose of this study is to define the significant predictors for caregiver burden and to find out the effect of social support network to the removal of caregiver burden. As a cross-sectional study, data was collected from convenience sampling by 59 face-to-face interviews and questionnaires including, the Demographic Questionnaire, the Caregiving Stress Questionnnaire, the Social Readjustment Rating Scale (SRRS), the Lubben Social Network Scale (LSNS), and the Caregiver Burden Inventory (CBI). The collected data were analyzed by test of independence, analysis of variance, pearson and Spearman correlation, and multiple regression analysis. Findings showed that most of the caregivers were females (66.1%), 93.2% of them were adolescents’ parents, and their average age was 47.3+ 7.5 years, 59% of caregivers were graduated from high schools, 84.7% of them remained married. They supported their family, and took care of their psychosis adolescents at their homes. Eighty-one percents of caregivers believed they were in good health conditions. Eighty-six percents of them had moderate psychosocial stress but they felt they could manage to maintain the network of social support system. Data revealed that caregivers received caregiving stress up to 10.73 (SD= 3.44, Range: 5~20). They spent at least 3.71 years (SD = 2.10) to take care of psychosis adolescents. And the psychosis adolescents were sent to hospital at least 1.22 times during the periods of illness. After analyzing the relationship between variables, the findings showed that it was no significantly different between the caregiver of demography among perceived health conditions, caregiving stress, psychosocial stress, social support network and burden. There was positive correlation among caregiving stress and caregiver burden, and were negative correlation among psychosocial stress, caregiver burden and social support network. There was no correlation between psychosocial stress and caregiver burden. Satisfaction of caregiving stress and social support network were the predictor of burden in caregivers of psychosis adolescents, especially the caregiving stress (βS= .50, t= 4.56, p < .001). These predictors explained 32.5% (F(3,55)=10.30,p<.001) variance of caregiver burden. The findings indicated that caregiving stress has direct positive effect on caregiver burden, and social support network has direct negative effect on caregiver burden. However, social support network has no moderating effect between caregiving stress and caregiver burden.
Lee, Su-Yu, et 李素玉. « The effects of health related help-seeking behaviors on caregivers’ burden and psychological health among primary caregiver of adolescents with major psychosis ». Thesis, 2007. http://ndltd.ncl.edu.tw/handle/72075391224264254077.
Texte intégralLivres sur le sujet "Major psychoses"
Beckmann, Helmut, et Peter Riederer, dir. Pathochemical Markers in Major Psychoses. Berlin, Heidelberg : Springer Berlin Heidelberg, 1985. http://dx.doi.org/10.1007/978-3-642-69743-2.
Texte intégralDr, Beckmann H., Riederer P et Ackenheil M, dir. Pathochemical markers in major psychoses. Berlin : Springer-Verlag, 1985.
Trouver le texte intégralLectures in psychiatry : The functional psychoses : the schizophrenias and major affective disorders. St. Louis, Mo., U.S.A : W.H. Green, 1985.
Trouver le texte intégral1945-, Kane John M., et Collegium Internationale Neuro-psychopharmacologicum Congress, dir. Risperidone : Major progress in antipsychotic treatment : satellite symposium at the 17th Congress of Collegium Internationale Neuro-Psychopharmacologicum. Oxford : Oxford Clinical Communications, 1991.
Trouver le texte intégralFreud, Sigmund. The major works of Sigmund Freud. 2e éd. Chicago : Encyclopædia Britannica, Inc., 1990.
Trouver le texte intégralD, Burrows Graham, Norman Trevor R. 1946- et Davies Brian 1928-, dir. Antipsychotics. Amsterdam : Elsevier, 1985.
Trouver le texte intégralPathochemical Markers in Major Psychoses. Springer, 2011.
Trouver le texte intégralRiederer, P., H. Beckmann et M. Ackenheil. Pathochemical Markers in Major Psychoses. Springer London, Limited, 2012.
Trouver le texte intégralPathochemical Markers in Major Psychoses. Springer, 2011.
Trouver le texte intégralPriest, Robert G., et J. Steinert. Insanity : A Study of Major Psychiatric Disorders. Taylor & Francis Group, 2016.
Trouver le texte intégralChapitres de livres sur le sujet "Major psychoses"
Rafaelsen, Ole J. « Peptides in Major Psychoses ». Dans Biological Psychiatry, Higher Nervous Activity, 57–60. Boston, MA : Springer US, 1985. http://dx.doi.org/10.1007/978-1-4684-8329-1_8.
Texte intégralJellinger, K. « Neuromorphological Background of Pathochemical Studies in Major Psychoses ». Dans Pathochemical Markers in Major Psychoses, 1–23. Berlin, Heidelberg : Springer Berlin Heidelberg, 1985. http://dx.doi.org/10.1007/978-3-642-69743-2_1.
Texte intégralVan Kammen, D. P., Lee S. Mann, Mika Scheinin, Philip T. Ninan, Welmoet B. Van Kammen et Markku Linnoila. « Decreased Spinal Fluid Monoamine Metabolites and Norepinephrine in Schizophrenic Patients with Brain Atrophy ». Dans Pathochemical Markers in Major Psychoses, 88–95. Berlin, Heidelberg : Springer Berlin Heidelberg, 1985. http://dx.doi.org/10.1007/978-3-642-69743-2_10.
Texte intégralDemisch, L., F. Reinhuber et H. J. Bochnik. « The Use of Platelet Monoamine Oxidase in Multifactorial Research on Endogenous Psychoses ». Dans Pathochemical Markers in Major Psychoses, 96–109. Berlin, Heidelberg : Springer Berlin Heidelberg, 1985. http://dx.doi.org/10.1007/978-3-642-69743-2_11.
Texte intégralMueller, E. A., L. J. Siever et D. L. Murphy. « Neuroendocrine Responses to Serotonin Agonists as Possible Markers of the Functional State of Serotonergic Neurotransmission in Psychiatric Disorders ». Dans Pathochemical Markers in Major Psychoses, 110–28. Berlin, Heidelberg : Springer Berlin Heidelberg, 1985. http://dx.doi.org/10.1007/978-3-642-69743-2_12.
Texte intégralJimerson, D. C., et W. Berrettini. « Cerebrospinal Fluid Amine Metabolite Studies in Depression : Research Update ». Dans Pathochemical Markers in Major Psychoses, 129–43. Berlin, Heidelberg : Springer Berlin Heidelberg, 1985. http://dx.doi.org/10.1007/978-3-642-69743-2_13.
Texte intégralGattaz, Wagner F., T. Gasser et H. Beckmann. « CSF Studies in Schizophrenia : A Multidimensional Approach ». Dans Pathochemical Markers in Major Psychoses, 144–53. Berlin, Heidelberg : Springer Berlin Heidelberg, 1985. http://dx.doi.org/10.1007/978-3-642-69743-2_14.
Texte intégralGabriel, E. « The Significance of Psychopathological Classification in Interpreting Biochemical Findings ». Dans Pathochemical Markers in Major Psychoses, 24–28. Berlin, Heidelberg : Springer Berlin Heidelberg, 1985. http://dx.doi.org/10.1007/978-3-642-69743-2_2.
Texte intégralReynolds, G. P. « Receptors, Neuroleptics and Dopamine Concentrations in Schizophrenia — Postmortem Studies of Human Brain Tissue ». Dans Pathochemical Markers in Major Psychoses, 29–34. Berlin, Heidelberg : Springer Berlin Heidelberg, 1985. http://dx.doi.org/10.1007/978-3-642-69743-2_3.
Texte intégralRiederer, P., et G. P. Reynolds. « Brain Biochemistry in Schizophrenia : An Assessment ». Dans Pathochemical Markers in Major Psychoses, 35–43. Berlin, Heidelberg : Springer Berlin Heidelberg, 1985. http://dx.doi.org/10.1007/978-3-642-69743-2_4.
Texte intégralActes de conférences sur le sujet "Major psychoses"
« O-036 - CLINICAL DIFFERENCES BETWEEN PATIENTS WITH AND WITHOUT SUBSTANCE-INDUCED PSYCHOTIC SYMPTOMS WHO HAVE A LIFETIME MAJOR DEPRESSIVE DISORDER AND A SUBSTANCE USE DISORDER ». Dans 24 CONGRESO DE LA SOCIEDAD ESPAÑOLA DE PATOLOGÍA DUAL. SEPD, 2022. http://dx.doi.org/10.17579/abstractbooksepd2022.o036.
Texte intégral« PS-048 - ABORDAJE DEL CONSUMO DE CANNABIS Y ESQUIZOFRENIA : A PROPÓSITO DE UN CASO. » Dans 24 CONGRESO DE LA SOCIEDAD ESPAÑOLA DE PATOLOGÍA DUAL. SEPD, 2022. http://dx.doi.org/10.17579/abstractbooksepd2022.ps048.
Texte intégral« EPIDEMIOLOGICAL CHARACTERISTICS OF A SAMPLE OF PATIENTS WITH SUBSTANCE USE FROM THE PSYCHIATRIC CARE UNIT OF THE SOCIAL AFFAIRS SERVICE OF THE UNIVERSITY OF SALAMANCA ». Dans 23° Congreso de la Sociedad Española de Patología Dual (SEPD) 2021. SEPD, 2021. http://dx.doi.org/10.17579/sepd2021p019v.
Texte intégral« PV-045 - CONSUMO DE CANNABIS Y DESARROLLO DE PSICOSIS : A PROPÓSITO DE UN CASO CLÍNICO ». Dans 24 CONGRESO DE LA SOCIEDAD ESPAÑOLA DE PATOLOGÍA DUAL. SEPD, 2022. http://dx.doi.org/10.17579/abstractbooksepd2022.pv045.
Texte intégralGonçalves, Maria João, Rita André, Joana Romão, Rodrigo Saraiva, Gabriela Andrade, Elsa Fernandes, Manuela Abreu et Fátima Ismail. « PRIMER EPISODIO PSICÓTICO Y EL CONSUMO DE CANNABIS : ¿CUÁL ES EL IMPACTO EN LA COGNICIÓN ? » Dans 23° Congreso de la Sociedad Española de Patología Dual (SEPD) 2021. SEPD, 2021. http://dx.doi.org/10.17579/sepd2021o020.
Texte intégral« EL BOOM DE LA AYAHUASCA. A PROPÓSITO DE UN CASO. A PROPÓSITO DE UN CASO ». Dans 23° Congreso de la Sociedad Española de Patología Dual (SEPD) 2021. SEPD, 2021. http://dx.doi.org/10.17579/sepd2021p149v.
Texte intégral